702 results on '"Sullenger, Bruce A."'
Search Results
2. Aptameric hirudins as selective and reversible EXosite-ACTive site (EXACT) inhibitors
3. Rapid molecular imaging of active thrombi in vivo using aptamer-antidote probes
4. Acquired von Willebrand syndrome during extracorporeal membrane oxygenation support: a comprehensive review of current evidence: communication from the ISTH SSC on perioperative and critical care thrombosis and hemostasis
5. Utilizing directed evolution to interrogate and optimize CRISPR/Cas guide RNA scaffolds
6. Design of therapeutic biomaterials to control inflammation
7. Mixed-surface polyamidoamine polymer variants retain nucleic acid-scavenger ability with reduced toxicity
8. Anti-PEG Antibodies Inhibit the Anticoagulant Activity of PEGylated Aptamers
9. Targeting DAMPs with nucleic acid scavengers to treat lupus
10. DAMPs/PAMPs induce monocytic TLR activation and tolerance in COVID-19 patients; nucleic acid binding scavengers can counteract such TLR agonists
11. Aptamer-based factor IXa inhibition preserves hemostasis and prevents thrombosis in a piglet model of ECMO
12. Generation of an anticoagulant aptamer that targets factor V/Va and disrupts the FVa-membrane interaction in normal and COVID-19 patient samples
13. β-Cyclodextrin-containing polymer treatment of cutaneous lupus and influenza improves outcomes
14. MicroRNA let-7b enhances spinal cord nociceptive synaptic transmission and induces acute and persistent pain through neuronal and microglial signaling.
15. Polymer-Mediated Inhibition of Pro-invasive Nucleic Acid DAMPs and Microvesicles Limits Pancreatic Cancer Metastasis
16. T-cell count and T-cell telomere length in patients with severe COVID-19
17. Age and Comorbidities Predict COVID-19 Outcome, Regardless of Innate Immune Response Severity: A Single Institutional Cohort Study
18. Contributors
19. Aptamer-based protein inhibitors
20. Enhancing cardiac reprogramming via synthetic RNA oligonucleotides
21. An RNA aptamer exploits exosite-dependent allostery to achieve specific inhibition of coagulation factor IXa.
22. Aptamers as Reversible Sorting Ligands for Preparation of Cells in Their Native State
23. In Vivo Selection Against Human Colorectal Cancer Xenografts Identifies an Aptamer That Targets RNA Helicase Protein DHX9.
24. 135: AGE AND COMORBIDITIES PREDICT COVID-19 OUTCOME REGARDLESS OF SEVERITY OF INNATE IMMUNE RESPONSE
25. Protocol for purification of cells in their native state using reversible aptamer-antidote pairs
26. HTRS2023.O6B.2 Allosteric regulation of coagulation factor IXa
27. Tunable cytotoxic aptamer–drug conjugates for the treatment of prostate cancer
28. Abstract 2008 The Latent State of Protease Domain in Coagulation Factor IXa Discovered by X-Ray Crystallography Provides Exosite-Mediated Allosteric Control of Blood Clotting
29. Functional reprogramming of peripheral blood monocytes by soluble mediators in patients with pancreatic cancer and intraductal papillary mucinous neoplasms
30. Inhibition of Rat Corneal Angiogenesis by a Nuclease-Resistant RNA Aptamer Specific for Angiopoietin-2
31. Differential Induction of Immunogenic Cell Death and Interferon Expression in Cancer Cells by Structured ssRNAs
32. Nucleic acid scavenging microfiber mesh inhibits trauma-induced inflammation and thrombosis
33. Induction of Wild-Type p53 Activity in Human Cancer Cells by Ribozymes That Repair Mutant p53 Transcripts
34. Histone Deacetylase 7 In Murine Gram-Negative Acute Lung Injury
35. An Aptamer That Rapidly Internalizes into Cancer Cells Utilizes the Transferrin Receptor Pathway
36. Abstract 94: Randomized, Double-blind, Placebo-controlled Phase 1 Study Of Vwf-binding Aptamer, Bb-031: Safety, Tolerability, Pharmacokinetic And Pharmacodynamic Activity In Healthy Volunteers
37. Aptamers in Bordeaux, 24−25 June 2016
38. Scavenging nucleic acid debris to combat autoimmunity and infectious disease
39. From the RNA world to the clinic
40. Applications and future of aptamers that achieve rapid-onset anticoagulation
41. Rapid Molecular Imaging of Active Thrombi In Vivo Using Aptamer-Antidote Probes
42. Aptamer-programmable adeno-associated viral vectors as a novel platform for cell-specific gene transfer
43. SARS-CoV-2 viremia but not respiratory viral load is associated with ventilator complications
44. Dose-Dependent Von Willebrand Factor Inhibition by Aptamer BB-031 Correlates with Thrombolysis in a Microfluidic Model of Arterial Occlusion
45. X-Ray Structure of Thrombin Bound to a Heterobifunctional Aptamer-Drug Conjugate Reveals the Mechanistic Basis for a Novel Tethered Inhibition Strategy
46. Aptamer-Small Molecule Conjugates As Potent and Reversible Surgical Anticoagulants Targeting Thrombin
47. Notch Signaling in Cancer Stem Cells
48. Probing the Coagulation Pathway with Aptamers Identifies Combinations that Synergistically Inhibit Blood Clot Formation
49. Emerging applications of aptamers for anticoagulation and hemostasis
50. Abstract 16728: Translating Thrombolytic Efficacy of Von Willebrand Factor Aptamer Inhibition From a Small to Large Animal Model of Carotid Occlusion
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.